Objective: Secure proximal fixation of endografts to the infrarenal aortic neck is known to be important in the short-and long-term success of endovascular aneurysm repair. We sought to determine the relative importance of distal iliac fixation in preventing endograft migration and adverse clinical events after endovascular aneurysm repair. Positional stability of endografts is important in the long-term durability of endovascular aortic aneurysm repair (EVAR). Longitudinal displacement or migration of endovascular devices may lead to loss of fixation, development of type I endoleaks, and aneurysm rupture. The importance of proximal fixation of the device to the aortic wall in preventing endograft migration is well recognized.
Positional stability of endografts is important in the long-term durability of endovascular aortic aneurysm repair (EVAR). Longitudinal displacement or migration of endovascular devices may lead to loss of fixation, development of type I endoleaks, and aneurysm rupture. The importance of proximal fixation of the device to the aortic wall in preventing endograft migration is well recognized. [1] [2] [3] [4] Much attention has been paid to improving patient selection criteria with regard to aortic morphology and the development of proximal fixation designs that include hooks, barbs, and suprarenal fixation mechanisms. 3, 4 Although ex vivo and experimental studies indicate that penetrating hooks in proximal fixation mechanisms increase resistance to acute displacement, clinical migrations of such devices are seen. 5 The role of distal iliac fixation and longitudinal columnar support, however, has received little attention with regard to the maintenance of endograft positional stability. In vivo experimental studies have shown that increasing the iliac fixation length significantly increases the force needed to displace stent grafts that have longitudinal columnar support. 6 However, clinical reports of stent graft migration have not considered iliac fixation among the variables that could contribute to migration. Rather, they have focused on issues related to aortic neck morphology and angulation, device oversizing and positioning, type I endoleak, neck enlargement, and aneurysm size changes. [7] [8] [9] [10] The purpose of this study was to determine the relative importance of iliac fixation in preventing migration with the use of an endovascular device that is fully supported by an exoskeleton, thus providing meaningful longitudinal columnar support.
MATERIALS AND METHODS
From 1996 to 2003, 403 patients with infrarenal abdominal aortic aneurysms were treated with the AneuRx stent graft (Medtronic Vascular, Santa Rosa, Calif) at Stanford University Medical Center and prospectively followed up with serial imaging and clinical follow-up. In this analysis, we retrospectively reviewed the imaging and clinical data of all patients who had preoperative and at least two postprocedure computed tomography (CT) scans that allowed us to quantitatively assess both proximal and distal fixation lengths and to determine whether stent graft migration had occurred. A total of 173 patients had suitable serial CT imaging studies with follow-up extending to 84 months.
Spiral CT scans with and without intravenous nonionic contrast (300 mg/mL; volume, 120 mL) were performed by using a conventional CT protocol (scan parameters: 120 kVp, 280 mA, and 1 second; pitch 1:1; collimation 3 mm) with delayed imaging to identify endoleaks. Three-dimensional image analysis was performed with maximum-intensity projection, orthogonal centerline views, and curved planar reconstruction. The inferior border of the superior mesenteric artery (SMA) branch orifice was used as the reference point to quantitatively define longitudinal displacement of the stent graft. 11 Movement of the proximal margin of the stent graft of 5 mm or more in a caudal direction was considered to be significant. Stent graft migration was defined as caudal movement of 10 mm or more, relative to the SMA, on a sagittal CT image or movement of any distance if there was an adverse clinical event or if a secondary treatment was required. 12 Proximal and distal fixation lengths were calculated from the preprocedure and immediate postprocedure CT scans. Proximal fixation length was determined by subtracting the distance from the lowermost renal artery to the top of the stent graft from the preoperative neck length. Distal fixation length was determined by subtracting the distance from the end of the iliac limb to the iliac bifurcation from preoperative iliac artery length (distance from aortic bifurcation to iliac bifurcation). Proximal fixation was classified as good if the proximal fixation length was greater than 15 mm, intermediate if the proximal fixation length was 10 to 15 mm, and bad if the proximal fixation length was less than 10 mm. Distal fixation was classified as follows:
1. Good if the iliac fixation length was 25 mm or more and the distal end of the iliac limb was within 10 mm of the iliac bifurcation. 2. Intermediate if the iliac fixation length was 15 to 25 mm and the distal end of the iliac limb was within 10 mm of the iliac bifurcation or the iliac fixation length was 25 mm or more but the iliac limb was more than 10 mm from the iliac bifurcation.
3. Bad if the iliac fixation length was less than 25 mm and the iliac limb was greater than 10 mm from the iliac bifurcation (Fig 1) .
When the right and left iliac fixation lengths differed, the mean iliac values were used for patient classification. Baseline characteristics for the four patient groups were expressed as the mean and standard deviation for quantitative variables and percentages for binary variables. Because migration and adverse clinical outcomes are time dependent, statistical comparisons among the patient groups were performed on the basis of the number of events per 100 patient-years of follow-up, by using Kaplan-Meier survival estimates and the log-rank test. Outcome measures included migration, aneurysm rupture, surgical conversion, type I endoleak, aneurysm-related death, and overall survival. Cox proportional hazards regression was performed to evaluate the independent risk factors for migration by using the 5-mm movement criterion for migration (Ն5 mm caudal movement with respect to the SMA). Statistical significance was assumed if P Ͻ .05.
RESULTS
Stent graft migration of 10 mm or more was seen at some time in 17 (10%) of 173 patients during a mean follow-up time of 23 Ϯ 19 months. There were no significant differences between patients who sustained migration and those who had no migration in age or sex distribution and no differences in preoperative aortic neck diameter, neck length, or maximum aneurysm diameter (Table I) . Proximal and distal fixation lengths were determined on the first postimplantation CT scan and are shown in Table I . Patients with no migration had a greater iliac fixation length (30 Ϯ 12 mm) than those with migration (22 Ϯ 8 mm; P ϭ .01), and the distal ends of the iliac limbs were closer to the iliac bifurcation (15 Ϯ 12 mm) than in patients with migration (25 Ϯ 10 mm; P ϭ .001). Patients with no migration had a greater proximal aortic fixation length (23 Ϯ 12 mm) than migration patients (13 Ϯ 7 mm; P ϭ .001).
Patient demographics, aortic dimensions, and follow-up times of the four patient groups are shown in Table II . The proportion of women was higher (P ϭ .04) and the maximum aneurysm diameter was larger (P ϭ .002) in patients with poor fixation (group IV) compared with the goodfixation group (group I). Patients with the best proximal and distal fixation (group I) had the shortest mean follow-up time (16 Ϯ 15 months). Because long-term outcomes are time dependent, outcome variables were expressed in terms of 100 patient-years of follow-up for comparison among the groups (Table III) .
No stent graft migration was seen in group I (0/45; 0%) or group II (0/18; 0%) during the 2-year follow-up period. In both of these groups, patients had good iliac fixation, and no stent graft migration was observed regardless of whether the aortic fixation was good, intermediate, or bad. In patients with intermediate or bad iliac fixation and good aortic fixation (group III), migration occurred in 5 (9%) of 58 patients. Migration occurred in 12 (23%) of 52 patients with intermediate or bad iliac fixation and intermediate or bad aortic fixation (group IV). Four-year freedom from migration (10 mm) by Kaplan-Meier analysis in group I was 100%; in group II, it was 100%; in group III, it was 87%; and in group IV, it was 40%. The risk of migration was significantly higher in group IV compared with group I (P ϭ .0004; log-rank test; Fig 2) . Four-year freedom from movement (Ն5 mm) by Kaplan-Meier analysis in group I was 100%, in group II was 100%, in group III was 75%, and in group IV was 36%. The risk of movement was significantly higher in group IV compared with group I (P ϭ .007; log-rank test).
Cox proportional hazards regression modeling was performed to determine the factors predictive of migration (Table IV) . Significant factors predicting migration were iliac limbs more than 10 mm from the iliac bifurcation compared with the situation where iliac limbs were extended up to hypogastric artery (odds ratio, 17.2; P ϭ .01) and aortic fixation length (odds ratio 2.0 for each centimeter; P ϭ .007).
Aneurysm rupture occurred in one patient who had bad proximal aortic and intermediate iliac fixation on postimplantation CT scan. This patient underwent successful surgical conversion. Three patients have undergone elective surgical conversion with no mortality. All four conversion patients had intermediate or bad iliac fixation, and three of these patients also had intermediate or bad aortic fixation. There have been no aneurysm-related deaths. Freedom from surgical conversion at 4 years by Kaplan-Meier analysis in group I was 100%, in group II was 100%, in group III was 97%, and in group IV was 87%. There was no significant difference among the groups by log-rank test.
Type I endoleak was seen in 13 (7.5%) of 173 patients at some time during the follow-up period. Freedom from type I endoleak by Kaplan-Meier analysis at any time over 4 years in group I was 89%, in group II was 100%, in group III was 96%, and in group IV was 90% (not significant). In Cox proportional hazards regression modeling, proximal fixation length was a significant predictor for type I endoleak (odds ratio 2.2 for each centimeter; P ϭ .03). Thirty-two patients (18.5%) underwent 35 secondary procedures, including 4 surgical conversions and 31 secondary endovascular procedures, during the follow-up period. The primary indications for a secondary procedure were type I endoleak in 14 patients, type II endoleak in 11 patients, stent graft migration in 6 patients, and short fixation length with no migration in 1 patient. Secondary endovascular procedures included placement of proximal extender cuffs in six patients, placement of distal extender cuffs in four patients, and placement of both proximal and distal extender cuffs in five patients. In addition, endovascular procedures to treat type II endoleaks were performed in 13 patients.
At the completion of this study, 85% of the patients were alive. The 4-year Kaplan-Meier survival estimate for all patients was 66%. There were no significant differences in survival among the four patient groups, with Kaplan-Meier survival estimates at 4 years of 64% in group I, 58% in group II, 66% in group III, and 67% in group IV.
Nine patients with stent graft migration and bad iliac fixation were treated with secondary endovascular procedures to improve iliac fixation. Five patients required both proximal and distal extenders, and four patients needed only distal extender modules. In each case, the iliac limbs were extended to the level of the iliac bifurcation. No further stent graft migration has occurred in these patients during a mean follow-up of 12 Ϯ 15 months.
A subgroup of patients (n ϭ 43) with good proximal aortic fixation, good distal iliac fixation, and no evidence of endoleak on the first postprocedure CT scan was identified. During a mean follow-up of 23 Ϯ 18 months, none of these patients experienced any procedure-, device-, or aneurysmrelated adverse events. There were no migrations and no new endoleaks; no patient required a secondary procedure; and there were no surgical conversions, ruptures, or aneurysmrelated deaths. Thus, evidence of good proximal and distal fixation and no endoleak on the first postprocedure CT scan may portend a favorable long-term outcome.
DISCUSSION
The importance of proximal fixation of endografts in preventing migration is well known. [1] [2] [3] [4] However, the role of distal iliac fixation in preventing endograft migration has received little attention. Although iliac fixation may not play a major role in preventing migration of devices with penetrating hooks and suprarenal fixation, infrarenal devices that rely to some degree on longitudinal columnar support to achieve stability require secure iliac fixation. The AneuRx stent graft is such a device, deriving longitudinal columnar support from its complete Nitinol stent exoskeleton. Previous analyses of AneuRx stent graft migration have failed to take iliac fixation into consideration, focusing attention on characteristics of the infrarenal aortic neck and longitudinal displacement of the proximal end of the stent graft. 5, 8 No information has been provided in these reports on the status of iliac fixation in the patients who experienced migration. While in vivo experimental studies have demonstrated the importance of iliac fixation length in increasing resistance to stent graft displacement, 6 our study in the first to evaluate the importance of iliac fixation in preventing migration in patients treated with the AneuRx stent graft.
We found that the iliac fixation length on the first postimplantation CT scan was significantly greater in pa- tients who had no migration than in patients who experienced stent graft migration. Migration was observed only in patients with intermediate or bad iliac fixation, and no patient with good iliac fixation experienced stent graft migration during the follow-up period, even if there was suboptimal proximal aortic fixation. These findings demonstrate the importance of iliac fixation in preventing stent graft migration. However, to our surprise, Cox proportional hazards analysis did not identify iliac fixation length as an independent predictor of migration, whereas close proximity of the iliac limbs to the iliac bifurcation was a highly significant predictor of resistance to migration. Possible explanations for this disparity include measurement methods and definition of fixation length, as well as anatomic factors related to the positional stability of the iliac bifurcation in the pelvis. We considered two factors in our definition of good distal iliac fixation: common iliac artery fixation length and proximity of the distal end of the stent graft to the iliac bifurcation (hypogastric artery). These measurements were derived from retrospective analysis of preimplantation and postimplantation three-dimensional CT data with calculation of lengths by using centerline path measurements on curved planar reformation images. The distance from the end of the stent graft to the orifice of the hypogastric artery was a direct measurement, whereas iliac fixation length was determined by subtracting the distance from the end of the stent graft to the hypogastric artery from the length of common iliac artery (diameter Յ15 mm) on the preoperative CT scan. Although current AneuRx instructions for use include a recommendation for an iliac fixation length of 25 mm, iliac fixation was not monitored or measured during the AneuRx clinical trial and is not routinely assessed in current clinical practice. This is because although aortic neck anatomy and the common iliac artery diameter can be measured on axial CT scan images, iliac artery curvature and tortuosity prevent accurate measurement of length. Furthermore, iliac artery length may change during device implantation as a result of straightening of curvatures by the stiff guidewire and stiff endovascular device. Direct determination of iliac fixation length on postimplantation CT scans to account for potential shortening due to straight- ening is complicated by the fact that the aortic bifurcation and origin of the common iliac artery may be difficult to visualize because of the presence of the stent graft. Thus, the proximity of the distal end of the stent graft to the iliac artery bifurcation may be the most reliable imaging criterion for determining maximum common iliac fixation. We found that this measure was the single most important predictor for migration in our multivariate analysis and was more reliable than calculated iliac fixation length. Using both iliac fixation criteria, we considered iliac fixation to be good if the distal end of the iliac limb was within 10 mm of the hypogastric artery and bad if the distal end of the stent graft was more than 10 mm from the bifurcation and less than 25 mm in length. No migration occurred if the stent graft extended to the level of the iliac bifurcation, even if the common iliac arteries were as short as 20 mm. In contrast, migration was seen in cases where the iliac fixation length was 30 mm or more but the distance from the end of the stent graft to the iliac bifurcation was greater than 15 mm. Thus, it seems that the proximity of the stent graft to the iliac bifurcation, rather that absolute iliac fixation length, may be of primary importance in determining the stability of the stent graft. This may be due to the stability provided by the iliac bifurcation itself, which may be relatively fixed in place in the pelvis, compared with the potential mobility of long, tortuous common iliac arteries, which may become more tortuous over time, thus allowing downward displacement of the stent graft. Examples of good and bad stent graft fixation are shown in Fig 3. Our study also confirmed the importance of proximal aortic neck fixation in preventing stent graft migration. Proximal fixation length was significantly shorter in patients who experienced migration, and multivariate analysis identified short proximal fixation length as a significant predictor of migration. Similar findings were reported from a study of 1119 patients treated during the multicenter AneuRx clinical trial. 1 In this study, sequential CT image analysis by the independent Core Laboratory (University of Virginia, Charlottesville, VA) revealed that patients with subsequent stent graft migration had lower initial deployment of the stent graft below the renal arteries with greater renal to stent graft distance than patients with no migration. These differences were evident on the first postprocedure CT scan. In addition, Core Laboratory data revealed that there was significant variability in migration rates among the 13 clinical sites, with migration rates ranging from 0% to 30% (mean rate, 8%). Multivariate analysis revealed that the clinical implantation site was a highly significant predictor of subsequent migration, thus suggesting that factors other than the stent graft itself were of importance in determining long-term migration.
1 Unfortunately, no data were provided on iliac fixation or iliac fixation length. This is because these data were not measured or recorded by the Core Laboratory in its analysis of the CT scans. In addition, data on iliac fixation and iliac fixation length were not collected by clinical sites. Although adverse clinical events related to inadequate iliac fixation have been noted, 13 clinical studies of AneuRx stent graft migration have not taken iliac fixation into account. Our data suggest that studies focused on AneuRx stent graft migration must take iliac fixation into consideration in evaluating long-term outcome. It should be noted that the relative importance of iliac fixation and proximal fixation in preventing migration may be device specific, and our findings may not apply to other endovascular devices with different mechanical fixation systems.
The importance of stent graft fixation was first brought to light in an analysis of ruptures among patients treated during the course of the AneuRx clinical trial. 13 Seven of 1067 patients had late aneurysm ruptures, and, surprisingly, most (5 of 7) had no evidence of endoleak before rupture. However, all seven patients had CT scan evidence of poor stent graft fixation: four patients had inadequate proximal fixation, two patients had inadequate iliac fixation, and one patient had insufficient overlap at the modular junction. 13 These observations were made after completion of the clinical trial and Food and Drug Administration market approval in 1999 and led to modification in patient selection criteria and physician training programs. Elimination of endoleak was the primary end-point measurement during the clinical trial, and extender modules were used only if there was evidence of a type I endoleak. Postmarket training programs emphasize patient selection, implantation technique, and precision of device deployment immediately below the renal arteries, as well as the use of iliac extender modules to achieve good fixation. The benefits of this learning curve seem to be lower migration rates of 1% to 4% reported from studies of patients treated after completion of the AneuRx clinical trial 14, 15 compared with migration rates of 9% to 16% reported from studies conducted during the time of the AneuRx clinical trial. 8, 9, 16 Our study included patients treated both during the course of the clinical trial (1996-1999) and after market approval [2000] [2001] [2002] [2003] , with an overall migration rate of 10%. The combination of bad proximal aortic and bad distal iliac fixation resulted in the highest risk of migration, with 23% of such patients experiencing migration. In addition, proximal fixation was an important factor in sealing of the stent graft. Short proximal fixation length (Ͻ10 mm) was the most important predictor of type I endoleak and was strongly associated with the need for secondary endovascular procedures and surgical conversions. By contrast, type I endoleaks before migration and iliac artery tortuosity were not predictors of stent graft migration.
Only 36% of the patients in this study had good iliac fixation according to our current definition (groups I and II), and only 28% had good proximal and distal fixation (group I). This is because many of the patients in this study were treated early in our experience, during the AneuRx clinical trial and before we gained an appreciation of the importance of proximal and distal fixation. In addition, there have been significant improvements in imaging and technique that allow more precise device deployment. Thus, our analysis is complicated by the fact that the group with the best fixation and lowest migration rate (group I) also had the shortest follow-up time. In our early experience, we rarely used iliac extender modules unless there was evidence of a distal type I endoleak. Our current practice is to position the proximal end of the stent graft just below the renal arteries and extend the iliac limbs to the iliac bifurcation in all cases (Fig 3) . Whether this will eliminate the risk of migration in the long term remains to be seen.
Secondary procedures were seen in all groups regardless of iliac or aortic stent graft fixation status. Most secondary procedures were needed to treat endoleaks: 42% of secondary procedures were for type I endoleaks, and 33% were for treating type II endoleaks. Although there is no disagreement on the need to treat type I endoleaks, [17] [18] [19] the risk of rupture in patients with type II endoleaks is now thought to be very low, 20 and secondary treatments for type II endoleaks are diminishing. 21, 22 Secondary treatments to secure stent graft fixation and prevent or treat migration, conversely, are highly effective. Among nine patients with migration and bad iliac fixation, secondary treatment with iliac extender modules halted migration, with no evidence of further migration during a mean follow-up period of 12 months. This suggests that elective secondary procedures to increase iliac fixation length in patients with bad iliac fixation may be indicated to prevent the risk of stent graft migration.
EVAR has a lower operative mortality and more favorable short-term results than open surgical repair. 23, 24 However, the possibility of late adverse events after EVARsuch as aneurysm rupture, migration, and enlargement and the need for surgical conversion-is a continuing concern. Although the absence of endoleak has long been considered to be evidence of successful endovascular repair, late aneurysm ruptures have occurred in patients with no evidence of endoleak, 25, 26 thus limiting the usefulness of this finding for long-term assurance. This has led to widespread recommendations that all patients treated with EVAR should undergo lifelong follow-up with annual or semiannual imaging studies. Although preoperative CT imaging studies can identify patients with adverse morphologic features that may predispose them to late adverse clinical events, there has been little attention to favorable postimplantation CT image characteristics that identify patients who are at very low risk for late adverse events and, thus, may require less frequent CT image follow-up. In an effort to address this issue, we evaluated the long-term outcome of all patients with (1) evidence of good (Ͼ15 mm) aortic fixation, (2) good (within 10 mm of iliac bifurcation) iliac fixation, and (3) no evidence of endoleak on the first postimplantation CT scan. There were 43 such patients, and all had good outcomes, with no adverse events or changes in their CT image findings. There were no aneurysm ruptures, no aneurysm-related deaths, no stent graft migrations, no new endoleaks, no secondary procedures, and no surgical conversions during a 2-year follow-up period. Although this group represented only 25% of the patients reported in this series extending back to 1996, the percentage of patients in this category in our current practice is much higher. Prospective studies using well-defined imaging criteria on postimplantation CT scans with longer follow-up times are needed before changes are considered in the recommended follow-up image surveillance. However, these findings suggest that frequent, repeated CT scan imaging may not be required for all patients after EVAR.
CONCLUSIONS
Iliac fixation, along with proximal aortic fixation, is an important factor in preventing AneuRx stent graft migration. Close proximity of the distal end of the stent graft to the iliac bifurcation seems to provide the greatest stability against migration, and no migration was observed in patients who had good iliac fixation even in the presence of suboptimal aortic fixation. Stent graft migration may be prevented by extending the iliac limbs to the level of the iliac bifurcation at the time of initial device deployment. Patients with good proximal and distal fixation and no evidence of endoleak on postprocedure CT are unlikely to experience migration or adverse events or require a secondary procedure during the follow-up period.
INVITED COMMENTARY Timothy A.M. Chuter, MD, San Francisco, Calif
In the accompanying paper, Heikkinen et al present data showing that the extent of common iliac implantation, iliac fixation length, has no effect on the risk of migration. However, they did find evidence of an association between migration rate and a composite measure of implantation accuracy, based largely on the distance between the distal end of the stent-graft and the iliac bifurcation. It is not clear why this would be a more reliable indicator of distal stent-graft fixation than iliac fixation length.
The basic substrate for this analysis was a series of measurements, including proximal stent migration distance and the lengths of the aortic and iliac implantation sites. The best way to detect any association, positive or negative, between migration and iliac fixation would have been to assess correlations between these measurements. Instead, the authors changed their data from interval to ordinal form by applying arbitrary threshold criteria and incorporating other variables of uncertain significance. For example, group values of migration prevalence were substituted for individual values of migration distance. The division of migration data into present or absent may be important in a paper examining complication rates, but that rationale does not apply here. In theory, any degree of migration could have been used to assess the influence of a possible causative factor.
As the authors acknowledge, migration rates are time dependent. All other factors being equal, patients with longer follow-up, such as the study group with inaccurate implantation, will have higher rates. The data in Table III attempt to account for the time factor by representing migration rates as a function of the length of follow-up, but most of the other migration data are presented in a raw form, uncompensated for the effect of time. Moreover, there is no reason to assume that migration rate is a linear function of time, especially when assessed as an all-or-nothing phenomenon.
According to both the introduction and the discussion, this clinical study confirms the findings of animal studies, said to show "increasing iliac fixation length significantly increases the force needed to displace stent-grafts." Both studies are susceptible to alternative interpretations, however; and in my opinion, the animal study shows that packing additional graft limbs into a small experimental aneurysm limits the potential for stent-graft compression, nothing more.
Although many of the findings of this clinical study are difficult to explain, the observed variation in migration rates was probably multifactorial, with time dependent factors such as length of follow-up and evolving operative technique probably making the greatest contribution, and proximity to the iliac bifurcation the least.
